Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RS-61443' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 160 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Dipchand, AI; Benson, L; McCrindle, BW; Coles, J; West, L
      Mycophenolate mofetil in pediatric heart transplant recipients: A single-center experience

      PEDIATRIC TRANSPLANTATION
    2. Wiwattanawongsa, K; Heinzen, EL; Kemp, DC; Dupuis, RE; Smith, PC
      Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    3. Dipchand, AI; Pietra, B; McCrindle, BW; Rosebrook-Bicknell, HL; Boucek, MM
      Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    4. Cherney, DZI; Zaltzman, JS
      Mycophenolate mofetil causing deep venous thrombosis in a renal transplantpatient with factor V Leiden

      NEPHROLOGY DIALYSIS TRANSPLANTATION
    5. van Gelder, T; Klupp, J; Barten, MJ; Christians, U; Morris, RE
      Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

      THERAPEUTIC DRUG MONITORING
    6. Jain, A; Venkataramanan, R; Hamad, IS; Zuckerman, S; Zhang, SM; Lever, J; Warty, VS; Fung, JJ
      Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus

      JOURNAL OF CLINICAL PHARMACOLOGY
    7. Suleymanlar, G; Tuncer, M; Sarikaya, M; Ersoy, F; Aktan, S; Yakupoglu, G; Karpuzoglu, T
      The cost effectiveness of mycophenolate mofetil in the first year after living related renal transplantation

      TRANSPLANTATION PROCEEDINGS
    8. Grasser, B; Iberer, F; Schaffellner, S; Kniepeiss, D; Stauber, R; Koshsorur, G; Rehak, P; Tscheliessnigg, KH
      Trough level-guided mycophenolate mofetil rejection prophylaxis in liver transplantation

      TRANSPLANTATION PROCEEDINGS
    9. Foster, RD; Ascher, NL; McCalmont, TH; Neipp, M; Anthony, JP; Mathes, SJ
      Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.

      TRANSPLANTATION
    10. Pescovitz, M; Conti, D; Greenstein, SM; Inokuchi, S; Rosenthal, J; Cohen, D; Stiller, C; Pirsch, J; Tomlanovich, S; Cho, S; Deierhoi, M; Ferguson, R; Gonwa, T; Hodge, E; Keown, PA; Ramos, E; Navarro, MT
      Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: Three-year follow-up

      TRANSPLANTATION
    11. Piazza, A; Poggi, E; Borrelli, L; Servetti, S; Monaco, PI; Buonomo, O; Valeri, M; Torlone, N; Adorno, D; Casciani, CU
      Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: Posttransplant analysis using flow cytometric techniques

      TRANSPLANTATION
    12. Jones, NF; Hebebrand, D; Buttemeyer, R; Zhao, M; Benhaim, P; Rao, U
      Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: Implications for clinical composite tissue transplantation

      PLASTIC AND RECONSTRUCTIVE SURGERY
    13. Zurdel, J; Aboalchamat, B; Zierhut, M; Stubiger, N; Bialasiewicz, A; Engelmann, K
      Early clinical experiences with mycophenolate mofetil for immunosuppressive therapy of ocular cicatrical pemphigoid

      KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
    14. Mourad, M; Malaise, J; Eddour, DC; De Meyer, M; Konig, J; Schepers, R; Squifflet, JP; Wallemacq, P
      Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil

      CLINICAL CHEMISTRY
    15. Warrens, AN
      The evolving role of mycophenolate mofetil in renal transplantation

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    16. DeNofrio, D; Loh, E; Kao, A; Korecka, M; Pickering, FW; Craig, KA; Shaw, LM
      Mycophenolic acid concentrations are associated with cardiac allograft rejection

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    17. Tsaroucha, AK; Zucker, K; Esquenazi, V; de Faria, L; Miller, J; Tzakis, AG
      Levels of mycophenolic acid and its glucuronide derivative in the plasma of liver, small bowel and kidney transplant patients receiving tacrolimus and cellcept combination therapy

      TRANSPLANT IMMUNOLOGY
    18. Arbeiter, K; Greenbaum, L; Balzar, E; Muller, T; Hofmeister, F; Bidmon, B; Aufricht, C
      Reproducible erythroid aplasia caused by mycophenolate mofetil

      PEDIATRIC NEPHROLOGY
    19. Fellermann, K; Steffen, M; Stein, J; Raedler, A; Hamling, J; Ludwig, D; Loeschke, K; Stange, EF
      Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

      ALIMENTARY PHARMACOLOGY & THERAPEUTICS
    20. Haussmann, W
      Mechanisms of action of immunosuppressants and immunoinductors

      SECONDARY NEOPLASIAS FOLLOWING CHEMOTHERAPY, RADIOTHERAPY, AND IMMUNOSUPPRESSION
    21. Yoshida, S; Toyama, Y; Aoki, T; Nakamura, J; Odaira, H; Inagaki, Y
      Combination therapy with FK 506 and RS61443 for rejection following allogeneic small bowel transplantation in rats

      TRANSPLANTATION PROCEEDINGS
    22. Yamani, MH; Starling, RC; Goormastic, M; Van Lente, F; Smedira, N; McCarthy, P; Young, JB
      The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection

      TRANSPLANTATION
    23. Eugui, EM
      The present and future of immunosuppressive therapy.

      MEDICINA-BUENOS AIRES
    24. Geilen, CC; Orfanos-Boeckel, H; Offermann, G; Orfanos, CE
      Mycophenolate mofetil: a new immunosuppressive agent in dermatology and its potential indications

      HAUTARZT
    25. Brusa, P; Ceruti, M; Casullo, R; Dosio, F; Squiccimarro, G; Segoloni, GP; Cattel, L
      Pharmacokinetic monitoring of mycophenolate mofetil in kidney transplantedpatients

      FARMACO
    26. Renz, JF; Lightdale, J; Mudge, C; Bacchetti, P; Watson, J; Ascher, NL; Emond, JC; Rosenthal, P; Roberts, JP
      Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipients

      LIVER TRANSPLANTATION AND SURGERY
    27. Zuckermann, A; Klepetko, W; Birsan, T; Taghavi, S; Artemiou, O; Wisser, W; Dekan, G; Wolner, E
      Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    28. Gibson, SW; Valente, JF; Alexander, JW; Custer, DA; Babcock, GF; Ogle, CK
      The effect of nutritional immunomodulation on cardiac allograft survival in rats receiving mycophenolate mofetil, cyclosporine A, and donor-specific transfusion

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    29. Meiser, BM; Pfeiffer, M; Schmidt, D; Reichenspurner, H; Ueberfuhr, P; Paulus, D; von Scheidt, W; Kreuzer, E; Seidel, D; Reichart, B
      Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: Importance of mycophenolic acid therapeutic drug monitoring

      JOURNAL OF HEART AND LUNG TRANSPLANTATION
    30. Gummert, JF; Ikonen, T; Morris, RE
      Newer immunosuppressive drugs: A review

      JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    31. Ishikawa, H
      Mizaribine and mycophenolate mofetil

      CURRENT MEDICINAL CHEMISTRY
    32. Taylor, DO; Sharma, RC; Kfoury, AG; Renlund, DG
      Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine

      CLINICAL TRANSPLANTATION
    33. Vogl, M; Weigel, G; Seebacher, G; Griesmacher, A; Laufer, G; Muller, MM
      Evaluation of the EMIT Mycophenolic Acid Assay from Dade Behring

      THERAPEUTIC DRUG MONITORING
    34. Sanchez, V; Delgado, JF; Blasco, T; Dalmau, R; Morales, JM; Escribano, P; Tello, R; Hernandez, J; Velazquez, T; Sotelo, T; Gomez-Sanchez, MA; de la Calzada, CS
      Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy

      TRANSPLANTATION PROCEEDINGS
    35. Meiser, BM; Pfeiffer, M; Schmidt, D; Ueberfuhr, P; Reichenspurner, H; Paulus, D; von Scheidt, W; Kreuzer, E; Seidel, D; Reichart, B
      The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels

      TRANSPLANTATION PROCEEDINGS
    36. Kato, T; Ruiz, P; DeFaria, W; Weppler, D; Khan, F; Pinna, A; Nery, J; Tzakis, A
      Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection

      TRANSPLANTATION PROCEEDINGS
    37. Jones, JW; Ustuner, ET; Zdichavsky, M; Edelstein, J; Ren, XP; Maldonado, C; Ray, M; Jevans, AW; Breidenbach, WC; Gruber, SA; Barker, JH
      Long-term survival of an extremity composite tissue allograft with FK506-mycophenolate mofetil therapy

      SURGERY
    38. Pardo-Mindan, FJ; Errasti, P; Panizo, A; Sola, I; de Alava, E; Lozano, MD
      Decrease of apoptosis rate in patients with renal transplantation treated with mycophenolate mofetil

      NEPHRON
    39. Gummert, JF; Barten, MJ; Sherwood, SW; Van Gelder, T; Morris, RE
      Pharmacodynamics of immunosuppression by mycophenolic acid: Inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    40. Andersen, HO
      Heart allograft vascular disease - An obliterative vascular disease in transplanted hearts

      ATHEROSCLEROSIS
    41. Sigalet, DL; Thorne, PC; Williams, DC; Martin, GR; Yatscoff, RW
      Effect of combined immunosuppressive drug therapy on small intestinal nutrient transport in the rat

      CLINICAL BIOCHEMISTRY
    42. CARR RR; YOSHIDA EM; CHUNG SW; PARTOVI N
      PRIMARY INDUCTION WITH MYCOPHENOLATE MOFETIL AND CORTICOSTEROIDS IN ALIVER-TRANSPLANT RECIPIENT WITH HEPATORENAL-SYNDROME

      The Annals of pharmacotherapy
    43. DUTOIT D; MULLER C; PAGE B; LOUW J
      FETAL-RAT PANCREATIC TRANSPLANTATION - POSTTRANSPLANTATION DEVELOPMENT OF FETAL PANCREATIC ISO-GRAFT AND ALLOGRAFT AND SUPPRESSION OF REJECTION WITH MYCOPHENOLATE-MOFETIL (MMF) AND CYCLOSPORINE BASED IMMUNOSUPPRESSION

      Microscopy research and technique
    44. VANBRUGGEN MCJ; WALGREEN B; RIJKE TPM; BERDEN JHM
      ATTENUATION OF MURINE LUPUS NEPHRITIS BY MYCOPHENOLATE MOFETIL

      Journal of the American Society of Nephrology
    45. PENNY MJ; BOYD RA; HALL BM
      MYCOPHENOLATE-MOFETIL PREVENTS THE INDUCTION OF ACTIVE HEYMANN NEPHRITIS - ASSOCIATION WITH TH2 CYTOKINE INHIBITION

      Journal of the American Society of Nephrology
    46. MORRISSTIFF G; JUREWICZ WA
      SINGLE-CENTER EXPERIENCE WITH MYCOPHENOLATE MOFETIL FOR REFRACTORY REJECTION IN CADAVERIC RENAL-TRANSPLANTATION

      Transplant international
    47. SUZUKI S; KAKEFUDA T; AMEMIYA H; CHIBA K; HOSHINO Y; KAWAGUCHI T; KATAOKA H; RAHMAN F
      AN IMMUNOSUPPRESSIVE REGIMEN USING FTY720 COMBINED WITH CYCLOSPORINE IN CANINE KIDNEY-TRANSPLANTATION

      Transplant international
    48. MORGERA S; BUDDE K; LAMPE D; AHNERT V; FRITSCHE L; KUCHINKE S; NEUMAYER HH
      MYCOPHENOLATE MOFETIL PHARMACOKINETICS IN RENAL-TRANSPLANT RECIPIENTSON PERITONEAL-DIALYSIS

      Transplant international
    49. SMITH KGC; ISBEL NM; CATTON MG; LEYDON JA; BECKER GJ; WALKER RG
      SUPPRESSION OF THE HUMORAL IMMUNE-RESPONSE BY MYCOPHENOLATE MOFETIL

      Nephrology, dialysis, transplantation
    50. SARMIENTO JM; MUNN SR; PAYA CV; VELOSA JA; NGUYEN JH
      IS CYTOMEGALOVIRUS-INFECTION RELATED TO MYCOPHENOLATE-MOFETIL AFTER KIDNEY-TRANSPLANTATION - A CASE-CONTROL STUDY

      Clinical transplantation
    51. HEBEBRAND D; JONES NF; ZOHMAN G; RAO U; SOLEIMAN N
      LIMB XENOTRANSPLANTATION USING FK506 AND RS61443 IMMUNOSUPPRESSION

      Journal of reconstructive microsurgery
    52. CARL S; WIESEL M; STAEHLER G
      USE OF MYCOPHENOLATE MOFETIL FOR PREVENTI ON OF ACUTE REJECTION IN RENAL-TRANSPLANTATION

      Der Urologe
    53. McMurray, RW; Elbourne, KB; Lagoo, A; Lal, S
      Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus

      JOURNAL OF RHEUMATOLOGY
    54. KIBERD B; MACDONALD A
      MYCOPHENOLATE AND GLOMERULAR-DISEASE

      American journal of kidney diseases
    55. KOBASHIGAWA JA
      MYCOPHENOLATE MOFETIL IN CARDIAC TRANSPLANTATION

      Current opinion in cardiology
    56. JONES TR; HUMPHREY PA; BRENNAN DC
      TRANSPLANTATION OF VASCULARIZED ALLOGENEIC SKELETAL-MUSCLE FOR SCALP RECONSTRUCTION IN A RENAL-TRANSPLANT PATIENT

      Transplantation proceedings
    57. JORDAN ML; NARAGHI R; SHAPIRO R; SMITH D; VIVAS CA; SCANTLEBURY VP; GRITSCH HA; MCCAULEY J; RANDHAWA P; DEMETRIS AJ; MCMICHAEL J; FUNG JJ; STARZL TE
      TACROLIMUS FOR RESCUE OF REFRACTORY RENAL-ALLOGRAFT REJECTION

      Transplantation proceedings
    58. Senn, B; Rochat, P; Schwarzkopf, AK; Weinreich, T; Binswanger, U
      Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction

      TRANSPLANTATION PROCEEDINGS
    59. Reis, A; Reinhard, T; Sundmacher, R; Braunstein, S; Godehardt, E
      Mycophenolate mofetil and FK506: Two novel immunosuppressants in murine corneal transplantation

      TRANSPLANTATION PROCEEDINGS
    60. KOBASHIGAWA J; MILLER L; RENLUND D; MENTZER R; ALDERMAN E; BOURGE R; COSTANZO M; EISEN H; DUREAU G; RATKOVEC R; HUMMEL M; IPE D; JOHNSON J; KEOGH A; MAMELOK R; MANCINI D; SMART F; VALANTINE H
      A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE-MOFETIL IN HEART-TRANSPLANT RECIPIENTS

      Transplantation
    61. PESCOVITZ MD; CONTI D; GREENSTEIN SM; INOKUCHI S; ROSENTHAL J; COHEN D; STILLER C; PIRSCH J; TOMLANOVICH S; CHO S; DEIERHOI M; FERGUSON R; GONWA T; HODGE E; KEOWN PA; RAMOS E; NAVARRO MT
      MYCOPHENOLATE MOFETIL FOR THE TREATMENT OF A FIRST ACUTE RENAL-ALLOGRAFT REJECTION

      Transplantation
    62. JONES TR; HUMPHREY PA; BRENNAN DC
      TRANSPLANTATION OF VASCULARIZED ALLOGENEIC SKELETAL-MUSCLE FOR SCALP RECONSTRUCTION IN A RENAL-TRANSPLANT PATIENT

      Transplantation
    63. Vu, MD; Qi, S; Xu, D; Wu, J; Peng, J; Daloze, P; Sehgal, S; Leduc, B; Chen, H
      Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat

      TRANSPLANTATION
    64. Ustuner, ET; Zdichavsky, M; Ren, X; Edelstein, J; Maldonado, C; Ray, M; Jevans, AW; Breidenbach, WC; Gruber, SA; Barker, JH; Jones, JW
      Long-term composite tissue allograft survival in a porcine model with cyclosporine/mycophenolate mofetil therapy

      TRANSPLANTATION
    65. Odorico, JS; Pirsch, JD; Knechtle, SJ; D'Alessandro, A; Sollinger, HW
      A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.

      TRANSPLANTATION
    66. WIESEL M; CARL S
      A PLACEBO-CONTROLLED STUDY OF MYCOPHENOLATE MOFETIL USED IN COMBINATION WITH CYCLOSPORINE AND CORTICOSTEROIDS FOR THE PREVENTION OF ACUTE REJECTION IN RENAL-ALLOGRAFT RECIPIENTS - 1-YEAR RESULTS

      The Journal of urology
    67. SCHNULLE P
      MYCOPHENOLATE-MOFETIL IN COMPARISON WITH OTHER IMMUNOSUPPRESSIVE DRUGS

      Der Internist
    68. SCHMID T; HECHENLEITNER P; MARK W; FISCHER M; ROBERTS K; GEISEN F; KLIMA G; DIETZE O; KONWALINKA G; MARGREITER R
      2-CHLORODEOXYADENOSINE (CLADRIBINE) IN COMBINATION WITH LOW-DOSE CYCLOSPORINE PREVENTS REJECTION AFTER ALLOGENEIC HEART AND LIVER-TRANSPLANTATION IN THE RAT

      European surgical research
    69. SHAW LM; KORECKA M; VANBREEMAN R; NOWAK I; BRAYMAN KL
      ANALYSIS, PHARMACOKINETICS AND THERAPEUTIC DRUG-MONITORING OF MYCOPHENOLIC-ACID

      Clinical biochemistry
    70. REIS A; REINHARD T; SUNDMACHER R; BRAUNSTEIN C; GODEHARDT E
      EFFECT OF MYCOPHENOLATE MOFETIL, CYCLOSPORINE-A, AND BOTH IN COMBINATION IN A MURINE CORNEAL GRAFT-REJECTION MODEL

      British journal of ophthalmology
    71. HAUFS MG; BEISSERT S; GRABBE S; SCHUTTE B; LUGER TA
      PSORIASIS-VULGARIS TREATED SUCCESSFULLY WITH MYCOPHENOLATE MOFETIL

      British journal of dermatology
    72. YU C; SEIDEL K; NASH RA; DEEG HJ; SANDMAIER BM; BARSOUKOV A; SANTOS E; STORB R
      SYNERGISM BETWEEN MYCOPHENOLATE MOFETIL AND CYCLOSPORINE IN PREVENTING GRAFT-VERSUS-HOST DISEASE AMONG LETHALLY IRRADIATED DOGS GIVEN DLA-NONIDENTICAL UNRELATED MARROW GRAFTS

      Blood
    73. HOLT CD; SIEVERS TM; GHOBRIAL RM; ROSSI SJ; GOSS JA; MCDIARMID SV
      MYCOPHENOLATE-MOFETIL - EFFECTS ON CLINICAL TRANSPLANTATION

      Biodrugs
    74. HOOD KA; ZAREMBSKI DG
      MYCOPHENOLATE MOFETIL - A UNIQUE IMMUNOSUPPRESSIVE AGENT

      American journal of health-system pharmacy
    75. KLUPP J; BECHSTEIN WO; PLATZ KP; KECK H; LEMMENS HP; KNOOP M; LANGREHR JM; NEUHAUS R; PRATSCHKE J; NEUHAUS P
      MYCOPHENOLATE MOFETIL ADDED TO IMMUNOSUPPRESSION AFTER LIVER-TRANSPLANTATION - FIRST RESULTS

      Transplant international
    76. SIEVERS TM; ROSSI SJ; GHOBRIAL RM; ARRIOLA E; NISHIMURA P; KAWANO M; HOLT CD
      MYCOPHENOLATE MOFETIL

      Pharmacotherapy
    77. WOLFE EJ; MATHUR V; TOMLANOVICH S; JUNG D; WONG R; GRIFFY K; AWEEKA FT
      PHARMACOKINETICS OF MYCOPHENOLATE MOFETIL AND INTRAVENOUS GANCICLOVIRALONE AND IN COMBINATION IN RENAL-TRANSPLANT RECIPIENTS

      Pharmacotherapy
    78. TAYLOR DO
      THE USE OF TACROLIMUS AND MYCOPHENOLATE MOFETIL AFTER CARDIAC TRANSPLANTATION

      Current opinion in cardiology
    79. KITCHIN JES; POMERANZ MK; WASHENIK K; SHUPACK JL
      REDISCOVERING MYCOPHENOLIC-ACID - A REVIEW OF ITS MECHANISM, SIDE-EFFECTS, AND POTENTIAL USES

      Journal of the American Academy of Dermatology
    80. LANGMAN LJ; NAKAKURA H; THLIVERIS JA; LEGATT DF; YATSCOFF RW
      PHARMACODYNAMIC MONITORING OF MYCOPHENOLIC-ACID IN RABBIT HETEROTOPICHEART-TRANSPLANT MODEL

      Therapeutic drug monitoring
    81. SIMMONS WD; RAYHILL SC; SOLLINGER HW
      PRELIMINARY RISK-BENEFIT ASSESSMENT OF MYCOPHENOLATE MOFETIL IN TRANSPLANT REJECTION

      Drug safety
    82. CORNA D; MORIGI M; FACCHINETTI D; BERTANI T; ZOJA C; REMUZZI G
      MYCOPHENOLATE MOFETIL LIMITS RENAL DAMAGE AND PROLONGS LIFE IN MURINELUPUS AUTOIMMUNE-DISEASE

      Kidney international
    83. KOBASHIGAWA JA
      TREATMENT OF NONHEMODYNAMIC COMPROMISING REJECTION - CONVENTIONAL APPROACHES VS INDIVIDUALIZATION NEW IMMUNOSUPPRESSIVE DRUGS

      Transplantation proceedings
    84. KIRKLIN JK; BOURGE RC; MCGIFFIN DC
      RECURRENT OR PERSISTENT CARDIAC ALLOGRAFT-REJECTION - THERAPEUTIC OPTIONS AND RECOMMENDATIONS

      Transplantation proceedings
    85. SPADA M; ALESSIANI M; FERRARI P; IACONA I; ABBIATI F; VIEZZOLI A; REGAZZI MB; BELLINZONA G; DIONIGI P; ZONTA A
      TACROLIMUS AND MYCOPHENOLATE MOFETIL IN PIG SMALL-BOWEL TRANSPLANTATION - DIFFERENT PROTOCOLS AND THEIR OUTCOME

      Transplantation proceedings
    86. GAVLIK A; GOLDBERG MG; TSAROUCHA A; WEBB MG; KHAN RT; WEPPLER D; NERY JR; KHAN MF; ZUCKER K; VICIANA AL; MILLER JA; TZAKIS AG
      MYCOPHENOLATE MOFETIL RESCUE THERAPY IN LIVER-TRANSPLANT RECIPIENTS

      Transplantation proceedings
    87. VANLEEUWEN L; GUIFFRE AK; SEWELL WA; VOS BJ; RAINER S; ATKINSON K
      ADMINISTRATION OF MYCOPHENOLATE MOFETIL IN A MURINE MODEL OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION

      Transplantation
    88. JORDAN ML; NARAGHI R; SHAPIRO R; SMITH D; VIVAS CA; SCANTLEBURY VP; GRITSCH HA; MCCAULEY J; RANDHAWA P; DEMETRIS AJ; MCMICHAEL J; FUNG JJ; STARZL TE
      TACROLIMUS RESCUE THERAPY FOR RENAL-ALLOGRAFT REJECTION - 5-YEAR EXPERIENCE

      Transplantation
    89. MIZOBUCHI M; IWASAKI Y; SAKO K; KANEKO Y
      SUPPRESSION OF ACUTE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN LEWISRATS WITH A MYCOPHENOLIC-ACID DERIVATIVE

      Tohoku Journal of Experimental Medicine
    90. LAFFERTY ME; LANG S; MCGREGOR E; HENDERSON IS; JONES MC
      TREATMENT OF SEVERE ACUTE VASCULAR REJECTION IN A RENAL-ALLOGRAFT WITH MYCOPHENOLATE MOFETIL AND HIGH-DOSE STEROIDS

      Scottish Medical Journal
    91. VANRENTERGHEM Y
      THE USE OF MYCOPHENOLATE MOFETIL (CELLCEPT(R)) IN RENAL-TRANSPLANTATION

      Nephron
    92. PERICO N; REMUZZI G
      PREVENTION OF TRANSPLANT REJECTION - CURRENT TREATMENT GUIDELINES ANDFUTURE-DEVELOPMENTS

      Drugs
    93. KENAGY DN; COLE BR; MARKOVITZ BP; GRAHAM IL; LOWELL JA
      ONE PATIENTS EXPERIENCE WITH MYCOPHENOLIC-ACID

      Pediatric nephrology
    94. ALLISON AC; EUGUI EM
      PURINE METABOLISM AND IMMUNOSUPPRESSIVE EFFECTS OF MYCOPHENOLATE MOFETIL (MMF)

      Clinical transplantation
    95. SOLLINGER HW
      FROM MICE TO MAN - THE PRECLINICAL HISTORY OF MYCOPHENOLATE MOFETIL

      Clinical transplantation
    96. CONTI D; BAKER J; WYNN J; DEIERHOI M; STUART F; WOODLE E; FERGUSON R; GONWA T; PESCOVITZ M; STILLER C; MENDEZ R; ROSENTHAL J; PIRSCH J; COHEN D; CERILLI J; BARKER C; KAUFFMAN R; LINNA J; MONROE S; NAVARRO M; DUNN J; INOKUCHI S; TOMLANOVICH S; WILBURN R; LIGHT J; TOMLANOVICH SJ
      RESCUE THERAPY WITH MYCOPHENOLATE MOFETIL

      Clinical transplantation
    97. RENLUND DG; GOPINATHAN SK; KFOURY AG; TAYLOR DO
      MYCOPHENOLATE MOFETIL (MMF) IN HEART-TRANSPLANTATION - REJECTION PREVENTION AND TREATMENT

      Clinical transplantation
    98. MCDIARMID SV
      MYCOPHENOLATE MOFETIL IN LIVER-TRANSPLANTATION

      Clinical transplantation
    99. HODGE EE
      THE ROLE OF MYCOPHENOLATE MOFETIL IN CLINICAL RENAL-TRANSPLANTATION

      World journal of urology
    100. BEHREND M
      A REVIEW OF CLINICAL-EXPERIENCE WITH THE NOVEL IMMUNOSUPPRESSIVE DRUGMYCOPHENOLATE MOFETIL IN RENAL-TRANSPLANTATION

      Clinical nephrology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/10/20 alle ore 02:31:08